Related Experiment Video
Updated: Aug 9, 2026

06:27
Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
Published on: October 20, 2020
Revolutionizing Vial Surface Chemistry to Enhance Lyophilization Success: Poster Presented at PDA Week 2026
Diane M McCormick1, Evgeniia Vorozhbit2, Steve Nail2
1Nipro PharmaPackaging Americas diane.mccormick@nipro-group.com.
PDA Journal of Pharmaceutical Science and Technology
|August 7, 2026
Summary
Extreme temperatures during glass manufacturing cause surface changes, risking drug defects like fogging during lyophilization. New technology improves inner glass surfaces for enhanced lyophilized drug stability.
Area of Science:
- Materials Science
- Pharmaceutical Technology
- Chemical Engineering
Background:
- Glass manufacturing involves extreme temperatures, leading to component sublimation and re-sublimation.
- This process alters the inner glass surface layer, increasing defect risk in lyophilized drugs.
- Fogging is a common defect associated with altered inner glass surfaces during lyophilization.
Purpose of the Study:
- To present data on an innovative technology for improving inner glass surface conditions.
- To investigate the behavior of the inner glass surface during the lyophilization process.
- To mitigate defects in lyophilized drugs caused by glass surface alterations.
Main Methods:
- Utilized an innovative technology to treat glass surfaces.
- Analyzed the structural changes of the inner glass surface.
- Evaluated the behavior of the inner glass surface during lyophilization.
Main Results:
- The innovative technology yields exceptional inner surface conditions.
- Demonstrated controlled behavior of the inner glass surface during lyophilization.
- Reduced the risk of defects such as fogging in lyophilized drugs.
Conclusions:
- The developed technology effectively enhances inner glass surface properties for lyophilization.
- Optimized inner glass surfaces minimize drug defects, improving product quality and stability.
- This advancement offers a solution for producing high-quality lyophilized pharmaceuticals.

